Ever Source Wealth Advisors, LLC Tg Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 664 shares of TGTX stock, worth $26,095. This represents 0.0% of its overall portfolio holdings.
Number of Shares
664
Previous 400
66.0%
Holding current value
$26,095
Previous $12,000
116.67%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TGTX
# of Institutions
416Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$613 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$448 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$292 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$129 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$112 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.71B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...